If left unchecked, the ceramides downregulated protein kinase B (PKB; but also known as Akt), a second messenger in the insulin pathway, which placed the cow at increased risk of developing metabolic diseases (Jeẑek and Garlid, 1998; Haus et al., 2009; Rico et al., 2015). This evidence concerns the gene AKT1 and metabolic disease.